Inhibition of MST3, a STE20-type kinase, alleviates metabolic dysfunction-related steatohepatitis in mice without influencing the development of hepatocellular carcinoma - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inhibition of MST3, a STE20-type kinase, alleviates metabolic dysfunction-related steatohepatitis in mice without influencing the development of hepatocellular carcinoma

  • By

  • Jingjing Zhang

  • Xiangdong Gongye

  • Lohitesh Kovooru

  • Emma Andersson

  • Bernice Asiedu

  • Manoj Amrutkar

  • Nadia Gul

  • Caitlyn Myers

  • Sheri Booten

  • Dan Emil Lind

  • Ying Xia

  • Antonio Molinaro

  • Anetta Härtlova

  • Per Lindahl

  • Sue Murray

  • Margit Mahlapuu

  • March 24, 2026

Share

Original Source(s)

Inhibition of MST3, a STE20-type kinase, alleviates metabolic dysfunction-related steatohepatitis in mice without influencing the development of hepatocellular carcinoma

  • by Jingjing Zhang, Xiangdong Gongye, Lohitesh Kovooru, Emma Andersson, Bernice Asiedu, Manoj Amrutkar, Nadia Gul, Caitlyn Myers, Sheri Booten, Dan Emil Lind, Ying Xia, Antonio Molinaro, Anetta Härtlova, Per Lindahl, Sue Murray, Margit Mahlapuu

  • March 24, 2026

Related Content

Spatial single-cell omics: new insights into liver diseases

Efficacy and safety of transoral incisionless fundoplication in non-obese and obese adults: a population-based cohort study from the United States

Low Cholesterol and Liver Risk—The Mechanism Matters